In this study, we have examined intratype human papillomavirus (HPV) s
equence variation in a worldwide collection of cervical specimens. Twe
lve different HPV types including HPV-18, HPV-33, HPV-35, HPV-39, HPV-
45, HPV-51, HPV-52, HPV-58, HPV-59, HPV-68 (ME180), MM9/PAP238A (recen
tly designated HPV-73), and a novel partial genomic HPV sequence desig
nated MM4/W13B were analyzed in this study. Cervical specimens were co
llected as part of epidemiological investigations conducted in New Mex
ico and an international study of invasive cervical cancer (IBSCC). Sp
ecimens from several countries including Argentina, Brazil, Bolivia, B
enin, Cuba, Colombia, Chile, Germany, Mall, Panama, Paraguay, Spain, A
lgeria, Uganda, Guinea, Tanzania, Indonesia, Philippines, Thailand, an
d the United States were evaluated. Specimen DNAs were subjected to am
plification with the MY09/11 L1 consensus PCR system. The PCR products
were cloned, and an approximately 410-bp region in the L1 open readin
g frame was sequenced from 146 specimens (similar to 60,000 bp). Withi
n a single HPV type, nucleotide diversity varied between 0.2 and 2.9%
(i.e., between any pair of variants) and the majority of nucleotide ch
anges were synonymous (amino acid conserving). These data provide;info
rmation pertinent to HPV diagnostic probe development and are potentia
lly relevant to future rational vaccine strategies. Similarly, amino a
cid diversity varied between 0 and 5.1%. Some of these amino acid chan
ges may represent markers of intertype evolutionary relationships. Pre
suming that HPVs have evolved under the same constraints as their corr
esponding hosts, the limited genetic diversity observed for all HPVs s
tudied to date may reflect an evolutionary bottleneck occurring in bot
h virus and host populations.